Seven Eight Capital’s Audentes Therapeutics, Inc BOLD Stock Holding History

Seven Eight Capital’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-54,254	Closed	-$3.25M	–	819
2019 Q4	$3.25M	Buy	+54,254	New	+$2.04M	0.17%	178
2019 Q3	–	Sell	-26,596	Closed	-$1.01M	–	790
2019 Q2	$1.01M	Buy	+26,596	New	+$1.02M	0.05%	399

Seven Eight Capital's BOLD Position: Q1 2020 in Review

Seven Eight Capital sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 54,254 shares — an estimated $3.25M sold.

Seven Eight Capital first reported a position in BOLD in Q2 2019 and held it in 2 quarters. The position peaked at $3.25M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Seven Eight Capital reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Seven Eight Capital sold 54,254 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $3.25M.
Seven Eight Capital first reported a position in Audentes Therapeutics, Inc in Q2 2019 and held it in 2 quarters.
Seven Eight Capital's Audentes Therapeutics, Inc position peaked at $3.25M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Seven Eight Capital's 13F filing for Q1 2020, filed 14 May 2020.